Skip to Content

Elekta AB Class B EKTAF

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company's installed base of more than 4,850 linear accelerators and software is used in more than 6,000 hospitals globally. The company's sales are evenly distributed across geographies, with North and South America accounting for 28%; Europe, the Middle East, and Africa accounting for 37%; and Asia-Pacific contributing the remainder.

Contact
Kungstensgatan 18, Box 7593
Stockholm, 103 93, Sweden
T +46 858725400
Sector Healthcare
Industry Medical Instruments & Supplies
Most Recent Earnings Oct 31, 2021
Fiscal Year End Apr 30, 2022
Stock Type
Employees 4,522